The role of genetic polymorphisms in alcoholic liver disease

Alcohol and Alcoholism

Volumn 41, Issue 3, 2006, Pages 209-224

  Stickel, Felix ^a   Österreicher, Christoph H ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ALCOHOL; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ANGIOTENSINOGEN; ANTIOXIDANT; CD14 ANTIGEN; CONNECTIVE TISSUE GROWTH FACTOR; CYTOCHROME P450 2E1; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; LEPTIN; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MATRIX METALLOPROTEINASE; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANTIOXIDANT ACTIVITY; CLINICAL OBSERVATION; DEGRADATION KINETICS; DNA SEQUENCE; DRINKING BEHAVIOR; EXPERIMENTATION; EXTRACELLULAR MATRIX; FAMILY STUDY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HEREDITY; HUMAN; LINKAGE ANALYSIS; LIVER CIRRHOSIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; TWINS;

ANIMALS; ANTIOXIDANTS; CASE-CONTROL STUDIES; CYTOKINES; HUMANS; LIVER; LIVER DISEASES, ALCOHOLIC; POLYMORPHISM, GENETIC;

ANIMALIA;

EID: 33646202790     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agl011     Document Type: Review

References (123)

1. Adachi, M. and Ishii, H. (2002) Role of mitochondria in alcoholic liver disease. Free Radical Biology and Medicine 32, 487-491.
2. Agundez, J., Ladero, J., Diaz-Rubio, M. et al. (1996) RsaI polymorphism at the cytochrome P4502E1 locus is not related to the risk of alcohol-related severe liver disease. Liver 16, 380-383.
3. Armstrong, R. N. (1997) Structure, catalytic mechanism, and evolution of the glutathione transferases. Chemical Research in Toxicology 10, 2-18.
4. Arteel, G. E. (2003) Oxidants and antioxidants in alcoholic liver disease. Gastroenterology 124, 778-790.
5. Ball, D. M., Sherman, D., Gibb, R. et al. (1995) No association between the c2 allele at the cytochrome P450IIE1 gene and alcohol induced liver disease, Korsakoff's syndrome or alcohol dependence syndrome. Drug and Alcohol Dependence 39, 181-184.
6. Bataller, R. and Brenner, D. A. (2001) Hepatic stellate cells as a target for the treatment of liver fibrosis. Seminars in Liver Disease 21, 437-451.
7. Bataller, R. and Brenner, D. A. (2005) Liver fibrosis. Journal of Clinical Investigation 115, 209-218.
8. Bataller, R., North, K. E. and Brenner, D. A. (2003) Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal. Hepatology 37, 493-503.
9. Bathgate, A. J., Pravica, V., Perrey, C. et al. (2000) Polymorphisms in tumor necrosis factor alpha, interleukin-10 and transforming growth factor β 1 genes and end-stage liver disease. European Journal Gastroenterology and Hepatology 12, 1329-1333.
10. Bellentani, S., Saccoccio, G., Costa, G. et al. (1997) Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 41, 845-850.
11. Benyon, R. C. and Arthur, M. J. (2001) Extracellular matrix degradation and the role of hepatic stellate cells. Seminars in Liver Disease 21, 351-372.
12. Borras, E., Coutelle, C., Rosell, A. et al. (2000) Genetic polymorphism of alcohol dehydrogenase in Europeans: The ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology 31, 984-989.
13. Bosron, W. F., Ehrig, T. and Li, T. K. (1993) Genetic factors in alcohol metabolism and alcoholism. Seminars in Liver Disease 13, 126-135.
14. Brind, A., Fryer, A., Hurlstone, A. et al. (2003) The role of polymorphism in manganese superoxide dismutase in susceptibility to alcoholic liver disease. Gastroenterology 124, 2000-2002.
15. Brind, A. M., Hurlstone, A., Edrisinghe, D. et al. (2004) The role of polymorphisms of glutathione-S-transferases GSTM1, M3, P1, T1 and A1 in susceptibility to alcoholic liver disease. Alcohol and Alcoholism 39, 478-483.
16. Burim, R. V., Canalle, R., Martinelli Ade, L. et al. (2004) Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P4502E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. Mutagenesis 19, 291-298.
17. Cardon, L. R. and Bell, J. I. (2001) Association study designs for complex diseases. Nature Reviews 2, 91-99.
18. Cardon, L. R. and Palmer, L. J. (2003) Population stratification and spurious allelic association. Lancet 361, 598-604.
19. Carr, L. G., Hartleroad, J. Y., Liang, Y. et al. (1995) Polymorphism at the P450IIE1 locus is not associated with alcoholic liver disease in Caucasian men. Alcohol: Clinical and Experimental Research 19, 182-184.
20. Carr, L. G., Yi, I. S., Li, T. K. and Yin, S. J. (1996) Cytochrome P4502E1 genotypes, alcoholism, and alcoholic cirrhosis in Han Chinese and Atayal Natives of Taiwan. Alcohol: Clinical and Experimental Research 20, 43-46.
21. Ceni, E., Galli, A. and Casini, A. (1997) Genetic, alcohol, and cirrhosis. Annals of Internal Medicine 126, 1000.
22. Chao, Y. C., Liou, S. R., Chung, Y. Y. et al. (1994) Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology 19, 360-366.
23. Chao, Y.-C., Young, T.-H., Chang, W.-K. et al. (1995) An investigation of whether polymorphisms of cytochrome P4502E1 are genetic markers of susceptibility to alcoholic en-stage organ damage in a Chinese population. Hepatology 22, 1409-1414.
24. Chao, Y. C., Young, T. H., Tang, H. S. et al. (1997) Alcoholism and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in Chinese patients. Hepatology 25, 112-117.
25. Colhoun, H. M., McKeigue, P. M. and Davey Smith, G. (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361, 865-872.
26. Corrao, G., Ferrari, P., Zambon A. et al. (1997) Trends of liver cirrhosis mortality in Europe, 1970-1989: Age-period-cohort analysis and changing alcohol consumption. International Journal of Epidemiology 26, 100-109.
27. Couzigou, P., Coutelle, C., Fleury, B. et al. (1994) Alcohol and aldehyde dehydrogenase genotypes, alcoholism and alcohol related disease. Alcohol and Alcoholism 2, 21-27.
28. Couzigou, P., Fleury, B., Groppi, A. et al. (1990) Genotyping study of alcohol dehyrogenase class I polymorphism in French patients with alcoholic cirrhosis. Alcohol and Alcoholism 25, 623-626.
29. D'Alfonso, S. and Richiardi, P. M. (1994) polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39, 150-154.
30. Daly, A. K. (2003) Candidate gene case-control studies. Pharmacogenomics 4, 1-13.
31. Danis, V. A., Millington, M., Hyland, V. J. et al. (1995) Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1RA) gene polymorphism. Clinical and Experimental Immunology 99, 303-310.
32. Darvasi, A. (1998) Experimental strategies for the genetic dissection of complex traits in animal models. Nature Genetics 18, 19-24.
33. Day, C. P. (2003) Host genetic factors and the progression of liver diseases; In Progress in the treatment of liver diseases. Arroyo, V., Forns, X., Pagan, J. G., Rodes, J. eds, pp. 453-462. Ars Medica, Barcelona.
34. Day, C. P., Bashir, R., James, O. F. et al. (1991) Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-orgen damage. Hepatology 14, 798-801.
35. Degoul, F., Sutton, A., Mansouri, A. et al. (2001) Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology 120, 1468-1474.
36. Deng, H. W. (2001) Population admixture may appear to mask, change or reverse genetic effects of genes underlying complex traits. Genetics 159, 1319-1323.
37. Duester, G., Farres, J., Felder, M. R. et al. (1999) Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. Biochemical Pharmacology 58, 389-395.
38. Frenzer, A., Butler, W. J., Norton, I. D. et al. (2002) Polymorphism in alcohol-metabolizing enzymes, glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis. Journal of Gastroenterology and Hepatology 17, 177-182.
39. Friedman, S. L. (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. Journal of Biological Chemistry 275, 2247-2250.
40. Gambaro, G., Anglani, F. and D'Angelo, A. (2000) Association studies of genetic polymorphisms and complex disease. Lancet 355, 308-311.
41. Groppi, A., Coutelle, C., Fleury, B. et al. (1991) Glutathione S-transferase class mu in French alcoholic cirrhostic patients. Human Genetics 87, 628-630.
42. Grove, J., Brown, A. S., Daly, A. K. et al. (1998) The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype. Pharmacogenetics 8, 335-342.
43. Grove, J., Daly, A. K., Bassendine, M. F. et al. (1997) Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic hepatitis. Hepatology 26, 143-146.
44. Grove, J., Daly, A. K., Bassendine, M. F. et al. (2000) Interleukin 10 promoter region polymorphism and susceptibility to advanced alcoholic liver disease. Gut 46, 540-545.
45. Hayashi, S., Watanabe, J. and Kawajiri, K. (1991) Genetic polymorphisms in the 5′ flanking region change transcriptional regulation of the human cytochrome P450 IIE1 gene. Journal of Biochemistry 110, 559-565.
46. Hayes, J. D., Flannagan, J. U. and Jowsey, I. R. (2005) Glutathione transferases. Annual Review of Pharmacology and Toxicology 45, 51-88.
47. Herbst, H., Wege, T., Milani, S. et al. (1997) Tissue inhibitor of metalloproteinase-1 and -2 mRNA expression in rat and human liver fibrosis. American Journal of Pathology 150, 1647-1659.
48. Hillebrandt, S., Goos, C., Matern, S. et al. (2002) Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome Gastroenterology 123, 2041-2051.
49. Hillebrandt, S., Matern, S. and Lammert, F. (2003) Mouse models for genetic dissection of polygenic gastrointestinal diseases. European Journal of Clinical Investigation 33, 155-160.
50. Hillebrandt, S., Wasmuth, H. E., Weiskirchen, R. et al. (2005) Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nature Genetics 37, 835-843.
51. Hines, I. N. and Wheeler, M. D. (2004) Recent advances in alcoholic liver disease. III Role of the innate immune response in alcoholic hepatitis. American Journal of Physiology: Gastrointestinal and Liver Physiology 287, G310-G314.
52. Hirschhorn, J. N., Lohmuller, K., Byrne, E. et al. (2002) A comprehensive review of genetic association studies. Genetics in Medicine 4, 45-61.
53. Homann, N., Stickel, F., Konig, I. R. et al. (2006) Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers. International Journal of Cancer, in press.
54. Hrubec, Z. and Omenn, G. S. (1981) Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: Twin concodance for alcoholism and its biological end points by zygosity among male veterans. Alcohol: Clinical and Experimental Research 5, 207-215. http://www.ncbi.nlm.nih.gov/SNP/.
55. Ioannidis, J. P., Ntzani, E. E., Trikalinos, T. A. et al. (2001) Replication validity of genetic association studies. Nature Genetics 29, 306-309.
56. Ioannidis, J. P., Trikalinos, T. A., Ntzani, E. E. et al. (2003) Genetic associations in large versus small studies: An empirical assessment. Lancet 361, 567-571.
57. Ishak, K. G., Zimmerman, H. J. and Ray, M. B. (1991) Alcoholic liver disease: Pathologic, pathogenetic and clinical aspects. Alcohol: Clinical and Experimental Research 15, 45-66.
58. Itoga, S., Nomura, F., Harada, S. et al. (1999) Mutation in the exons and exon-inton junction regions of human cytochrome P4502E1 gene and alcoholism. Alcohol: Clinical and Experimental Research 23, 13S-16S.
59. Järvelainen, H. A., Orpana, A., Perola, M. et al. (2001) Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 33, 1148-1153.
60. John, U. and Hanke, M. (2002) Alcohol-attributable mortality in a high per capita consumption country - Germany. Alcohol and Alcoholism 37, 581-585.
61. Kessova, I. and Cederbaum, A. I. (2003) CYP2E1: Biochemistry, toxicology, regulation and function in ethanol-induced liver injury. Current Molecular Medicine 3, 509-518.
62. Kim, W. R., Brown, R. S., Terrault, N. A. et al. (2002) Burden of liver disease in the United States: Summary of a workshop. Hepatology 36, 227-242.
63. Korstanje, R. and Paigen, B. (2002) From QTL to gene: The harvest begins. Nature Genetics 31, 235-236.
64. Krex, D., Rohl, H., König, I. R. et al. (2003) Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms. Stroke 34, 2817-2821.
65. Ladero, J. M., Fernandez-Arquero, M., Tudela, J. I. et al. (2002) Single nucleotide polymorphisms and microsattelite alleles of tumor necrosis factor alpha and interleukin-10 genes and the risk of advanced alcoholic liver disease. Liver 22, 245-251.
66. Ladero, J. M., Martinez, C., Garcia-Martin, E. et al. (2005) Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease. Scandinavian Journal of Gastroenterology 40, 348-353.
67. Lau, D. T., Luxon, B. A., Xiao, S. Y. et al. (2005) Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis. Hepatology 42, 273-281.
68. Lee, H. C., Lee, H. S., Jung, S. H. et al. (2001) Association between polymorphisms of ethanol-metabolizing enzymes and susceptibility to alcoholic cirrhosis in a Korean male population. Journal of Korean Medical Science 16, 745-750.
69. Lose, F., Thompson, P. J., Duffy, D. et al. (2005) A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women. Thorax 60, 623-628.
70. Lucas, D., Menez, C., Floch, F. et al. (1996) Cytochrome p4502E1 and p4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic Caucasians. Alcohol: Clinical and Experimental Research 20, 1033-1037.
71. Maezawa, Y., Yamauchi, M. and Toda, G. (1994) Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to alcoholic liver cirrhosis. American Journal of Gastroenterology 89, 561-565.
72. Monzoni, A., Masutti, F., Saccoccio, G. et al. (2001) Genetic determinants of alcohol-induced liver damage. Molecular Medicine 7, 255-262.
73. Morgan, T. R., Mandayam, S. and Jamal, M. M. (2004) Alcohol and hepatocellular carcinoma. Gastroenterology 127, S87-S96.
74. Nahon, P., Sutton, A., Pessayre, D. et al. (2005) Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death. Clinical Gastroenterology and Hepatology 3, 292-298.
75. Oliver, J., Agundez, J. A., Morales, S. et al. (2005) Polymorphisms in the transforming growth factor-beta gene (TGF-beta) and the risk of advanced alcoholic liver disease. Liver International 25, 935-939.
76. Osier, M. V., Pakstis, A. J., Goldman, D. et al. (2002) A proline-threonine substitution in codon 351 of ADH1C is common in Native Americans. Alcohol: Clinical and Experimental Research 26, 1759-1763.
77. Österreicher, C. H., Datz, C., Stickel, F. et al. (2005) TGFbeta1 gene polymorphism (codon 25 Arg(Pro) affects progression to cirrhosis in patients with hereditary hemochromatosis. Cytokine 31, 142-148.
78. Parlesak, A., Schäfer, C., Schutz, T. et al. (2000) Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. Journal of Hepatology 32, 742-747.
79. Parola, M. and Robino, G. (2001) Oxidative stress-related molecules and liver fibrosis. Journal of Hepatology 35, 297-306.
80. Parsian, A., Clonigner, C. R. and Zhang, Z. H. (1998) Association of polymorphisms of CYP2E1 gene in alcoholics with cirrhosis, antisocial personality, and normal controls. Alcohol: Clinical and Experimantal Research 22, 888-891.
81. Pastor, I., Laso, F. J., Avila, J. J. et al. (2000) Polymorphism in the interleukin-1 receptor antagonist gene is associated with alcoholism in Spanish men. Alcohol: Clinical and Experimental Research 24, 1479-1482.
82. Pastorelli, R., Bardazzi, G., Saieva, C. et al. (2001) Genetic determinants of alcohol addiction and metabolism: A survey in Italy. Alcohol: Clinical and Experimental Research 25, 221-227.
83. Pirmohamed, M., Kitteringham, N. R., Quest, L. J. et al. (1995) Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians. Pharmacogenetics 5, 351-357.
84. Plee-Gautier, E., Foresto, F., Ferrara, R. et al. (2001) Genetic repeat polymorphism in the regulation region of CYP2E1: Frequency and relationship with enzymatic activity in alcoholics. Alcohol: Clinical and Experimental Research 25, 800-804.
85. Powell, E. E., Edwards-Smith, C. J., Hay, J. L. et al. (2000) Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31, 828-833.
86. Raynard, B., Balian, A., Fallik, D. et al. (2002) Risk factors of fibrosis in alcoholic liver disease. Hepatology 35, 635-638.
87. Reed, T., Page, W. F., Viken, R. J. et al. (1996) Genetic disposition to organ-specific endpoints of alcoholism. Alcohol: Clinical and Experimental Research 20, 1528-1533.
88. Rodrigo, L., Alvarez, V., Rodriguez, M. et al. (1999) N-acetyltransferase-2, glutathione-S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: A case-control study. Scandinavian Journal of Gastroenterology 34, 303-307.
89. Satsangi, J., Chapman, R. W., Haldar, N. et al. (2001) A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology 121, 124-130.
90. Savolainen, V. T., Pajarinen, J., Perola, M. et al. (1996) Glutathione-S-transferase GSTM 'null' genotype and the risk of alcoholic liver disease. Alcohol: Clinical and Experimental Research 20, 1340-1345.
91. Savolainen, V. T., Pajarinen, J., Perola, M. et al. (1997) Polymorphism in the cytochrome P450 2E1 gene and the risk of alcoholic liver disease. Journal of Hepatology 26, 55-61.
92. Schuppan, D., Ruehl, M., Somasundaram, R. et al. (2001) Matrix as a modulator of hepatic fibrogenesis. Seminars in Liver Disease 21, 351-372.
93. Sherman, D. I., Ward, R. J., Warren-Perry, M. et al. (1993) Association of restriction fragment length polymorphism in alcohol dehydrogenase 2 gene with alcohol induced liver damage. British Medical Journal 307, 1388-1390.
94. Shimoda-Matsubayashi, S., Matsumine, H., Kobayashi, T. et al. (1996) Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochemical and Biophysical Research Communications 226, 561-565.
95. Stewart, S. F., Leathart, J. B., Chen, Y. et al. (2002) Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis. Hepatology 36, 1355-1360.
96. Stickel, F., Schuppan, D., Hahn, E. G. et al. (2002) Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 51, 132-139.
97. Stickel, F., Osterreicher, C. H., Datz, C. et al. (2005) Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis. Archives of Internal Medicine 165, 1835-1840.
98. Sutton, A., Khoury, H., Prip-Buus, C. et al. (2003) The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 13, 145-157.
99. Tabor, H. K., Risch, N. J. and Myers, R. M. (2002) Opinion: candidate-gene approaches for studying complex genetic traits: Practical considerations. Nature Reviews in Genetics 3, 391-397.
100. Takamatsu, M., Yamauchi, M., Maezawa, Y. et al. (1998) Correlation of a polymorphism in the interleukin-1 receptor antagonist gene with hepatic fibrosis in Japanese alcoholics. Alcohol: Clinical and Experimental Research 22, 141S-144S.
101. Takamatsu, M., Yamauchi, M., Maezawa, Y. et al. (2000) Genetic polymorphisms of interleukin-1beta in association with the development of alcoholic liver disease in Japanese patients American Journal of Gastroenterology 95, 1305-1311.
102. Tanaka, F., Shiratori, Y., Yokosuka, O. et al. (1996) High incidence of ADH2*1/ALDH2*1 genes among Japanese alcohol dependents and patients with alcoholic liver disease. Hepatology 23, 234-239.
103. Tanaka, F., Shiratori, Y., Yokosuka, O. et al. (1997) Polymorphism of alcohol-metabolizing genes affect: Drinking behavior and alcoholic liver disease in Japanese men. Alcohol: Clinical and Experimental Research 21, 596-601,
104. Teli, M. R., Day, C. P., Burt, A. D. et al. (1995) Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver Lancet 346, 987-980.
105. Tilg, H. and Diehl, A. M. (2000) Cytokines in alcoholic anc nonalcoholic steatohepatitis. New England Journal of Medicine 343, 1467-1476.
106. Tsutsumi, M., Takada, A. and Wang, J. S. (1994) Genetic polymorphism of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 107, 1430-1435.
107. Valenti, L., De Feo, T., Fracanzani, A. L. et al. (2004) Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients. Alcohol and Alcoholism 39, 276-280.
108. Vidal, F., Lorenzo, A., Auguet, T. et al. (2004) Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: Lack of association with alcoholism and alcoholic liver disease. Journal of Hepatology 41, 744-750.
109. Wallace, D. C. (1999) Mitochondrial disease in man and mouse. Science 283, 1482-1488.
110. Wang, Y. and Rannala, B. (2005) In silico analysis of disease-association mapping strategies using the coalescent process and incorporating ascertainment and selection. American Journal of Human Genetics 76, 1066-1073.
111. Wang, S. C., Ohata, M., Schrum, L. et al. (1998) Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. Journal of Biological Chemistry 273, 302-308.
112. Watanabe, J., Hayashi, S., Nakachi, K. et al. (1990) PstI and RsaI RFLP are in complete linkage disequilibrium at the CYP2E1 gene. Nucleic Acids Research 18, 7194.
113. Watanabe, J., Hayashi, S. and Kawajiri, K. (1994) Different regulaiton and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. Journal of Biochemistry 116, 321-326.
114. Wheeler, M. D., Kono, H., Yin, M. et al. (2001) The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radical Biology Medicine 31, 1544-1549.
115. Wiley, T. E., McCarthy, M., Breidi, L. et al. (1998) Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 28, 805-809.
116. Wilson, A. G., de Vries, N., Pociot, F. et al. (1993) An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8 and DR3 alleles. Journal of Experimental Medicine 177, 557-560.
117. Wilson, R. K., Chen, C., Avdalovic, N. et al. (1990) Development of an automated procedure for fluorescent DNA sequencing. Genomics 6, 626-634.
118. Wong, N. A., Rae, F., Simpson, K. J. et al. (2000) Genetic polymorphism of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: A study and literature review, including meta-analysis. Journal of Clinical Pathology/Molecular Pathology 53, 88-93.
119. Yamauchi, M., Maezawa, Y., Toda, G. et al. (1995a) Association of a restriction fragment length polymorphism in the alcohol dehydrogenase 2 gene with Japanese alcoholic liver cirrhosis. Journal of Hepatology 23, 519-523.
120. Yamauchi, M., Maezawa, Y., Mizuhara, Y. et al. (1995b) Polymorphism in alcohol metabolizing enzyme genes and alcoholic cirrhosis in Japanese patients: A multivariate analysis. Hepatology 22, 1136-1142.
121. Ye, S., Eriksson, P., Hamsten, A. et al. (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. Journal of Biological Chemistry 271, 13055-13060.
122. Younossi, Z. M., Baranova, A., Ziegler, K. et al. (2005) A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology 42, 665-674.
123. Yu, M. W., Gladek-Yarborough, A., Chiamprasert, S. et al. (1995) Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 109, 1266-1273.